Skip to main content
. 2017 Jan 15;10:75–80. doi: 10.1016/j.ymgmr.2017.01.002

Table 3.

Changes in CHQ-PF50 Z-scores (adjusted for age and gender) during treatment (Tx) versus placebo (PBO). > 0.5 SDS improvements are bolded.

Outcomes Treatment change
Placebo change
Difference Tx-PBO
Patient no.
Patient no.
Patient no.
1 2 1 2 1 2
PhS 1.0 0.7 0.0 0.6 1.0 0.1
PsS 0.4 0.4 − 0.8 0.3 1.2 0.1
GH 0.2 0.2 0.4 1.1 − 0.2 − 0.9
BP 0.0 0.5 − 1.4 − 0.5 1.4 1.0
PF 0.7 1.4 0.7 1.0 0.0 0.4
RP 1.8 0.0 0.0 0.0 1.8 0.0
PT 1.1 0.0 − 1.1 0.5 2.2 − 0.5
PE 0.0 1.2 − 0.4 0.8 0.4 0.4
REB 1.7 0.0 − 1.7 0.0 3.4 0.0
SE -0.5 0.2 0.0 0.9 − 0.5 − 0.7
MH 0.7 0.4 0.0 0.7 0.7 − 0.3
BE 0.0 0.5 − 0.7 − 1.0 0.7 1.5

PF = physical functioning; RP = role/social-physical; GH = general health; BP = bodily pain (lower = worse pain); PT = parental impact-time; PE = parental impact-emotional; REB = role/social-emotional/behavioral; SE = self-esteem; MH = mental health; BE = behavior; PhS = Physical Health Summary Score (PF, RP,GH, BP, PT, PE); PsS = Psychosocial Health Summary Score (PT, PE, REB, SE, MH, BE); increase means an improvement for all scales except BP (bodily pain) where increase in score = decrease in pain.